Merck initiates Phase 3 clinical trial of investigational oral KRAS G12C inhibitor MK-1084
For the first-line treatment of certain patients with metastatic non-small cell lung cancer
For the first-line treatment of certain patients with metastatic non-small cell lung cancer
This is the fourth authorized indication in Europe for Reblozyl, a first-in-class treatment for patients with disease-related anemia
For the treatment of stenotic lesions of arteriovenous fistula in the haemodialysis management of chronic renal failure
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
The report underscores significant advancements in healthcare delivery, showcasing how GenAI facilitates improved diagnostic accuracy, operational efficiency and patient engagement
Elegen is the only DNA manufacturer delivering the unique combination of complexity, length and NGS-verified accuracy within days
Versavo is the first Dr. Reddy's biosimilar product to be approved and launched in the UK
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
Subscribe To Our Newsletter & Stay Updated